Comorbid patient at a neurologist’s office. Questions and solutions 

The interdisciplinary conference with international participation Veynov Readings was held from February 8–10, 2023 in Moscow. As part of the conference, there was a symposium devoted to the topic «Comorbid patient at a neurologist’s office. Questions and solutions», dedicated to the use of peptides in the clinical practice of neurologists. The symposium presented an algorithm for the therapy of a comorbid patient with chronic cerebral ischemia (CCI) using preparations based on polypeptides of the cerebral cortex of cattle (PCCC) and cytochrome C. The principles of rational pharmacotherapy of a patient with postcovid syndrome (PCS) were considered, since PCS is commonly accompanied by the nervous system disorders, including vegetative, and can accompanied by the CI. The issues of the efficacy concerning the inclusion of PCCC and cytochrome C in the patient management with PCS were discussed. Since the problem of polypragmasia is relevant in modern neurology, the final report was devoted to how to avoid polypragmasia when prescribing peptide drugs. The proposed combination of cytochrome C and PCCC peptide preparations allows to summarize the therapeutic effects of non-selective cytoprotectors with significant antihypoxic properties and neuroprotectors affecting neuroplasticity and neurotrophy.

Keywords: polypeptides of the cerebral cortex of cattle, cytochrome C, chronic cerebral ischemia, postcovid syndrome, polypragmasia, neuroplasticity.

For citation: Shchukin I.A., Zhuravleva M.V., Putilina М.V. Comorbid patient at a neurologist’s office. Questions and solutions. RMJ. 2023;3:49–56.